Stephen M Ansell, M.D

Rare Disease / Clinical Research

Dana-Farber - Harvard Cancer Center LAO

ROCHESTER, MN

PI on 1 trial 5 publicationsNPI: 1558335935

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Primary effusion lymphoma
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement
Diffuse large B-cell lymphoma of the central nervous system
Aggressive primary cutaneous B-cell lymphoma
ALK-positive large B-cell lymphoma
T-cell/histiocyte rich large B cell lymphoma
Intravascular large B-cell lymphoma
Aggressive primary cutaneous T-cell lymphoma
Diffuse large B-cell lymphoma with chronic inflammation

Clinical trials (1)

NCT03038672

Verify independently

ClinicalTrials.gov PI search for Stephen M Ansell
PubMed author search
NPPES NPI registry entry

Other specialists for Primary effusion lymphoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

Richard F. Little, MD
NCI - HIV and AIDS Malignancy Branch
Robert Yarchoan, M.D.
National Cancer Institute (NCI)
Maryland
Ramya M Ramaswami, M.D.
National Cancer Institute (NCI)
Maryland
Pei Wang, PhD
Eureka Therapeutics Inc.
Wyndham H Wilson, M.D., MD, PhD
National Cancer Institute (NCI)
MD
Frank G Basile, M.D., MD
Schrodinger Inc.
RI
Ramya Ramaswami, M.D., MD MPH
National Cancer Institute (NCI)
MD
Amrita Krishnan, MD
City of Hope Medical Center
CA

See all specialists for Primary effusion lymphoma →

← Back to specialists directory